Gene Expression Analysis Reveals Evidence for Increased Expression of Cell Cycle-Associated Genes and Gq-Protein-Protein Kinase C Signaling in Cold Thyroid Nodules
Markus Eszlinger,
Knut Krohn,
Kerstin Berger,
Jürgen Läuter,
Siegfried Kropf,
Martin Beck,
Dagmar Führer and
Ralf Paschke
III. Medical Department (M.E., K.K., K.B., D.F., R.P.), and Interdisciplinary Center for Clinical Research Leipzig (K.K.), University of Leipzig, D-04103 Leipzig, Germany; Institute of Biometrics and Medical Informatics (J.L., S.K.), University of Magdeburg, D-39120 Magdeburg, Germany; and Interdisciplinary Center for Bioinformatics Leipzig (M.B.), University of Leipzig, D-04107 Leipzig, Germany
Address all correspondence and requests for reprints to: R. Paschke, M.D., III. Medical Department, University of Leipzig, Philipp-Rosenthal-Strasse 27, D-04103 Leipzig, Germany. E-mail: pasr{at}medizin.uni-leipzig.de.
In contrast to the molecular etiology of autonomously functioningthyroid nodules, the molecular cause of cold thyroid nodules(CTNs), their benign, functional inactive counterparts, areso far largely unknown. Because of the partially dedifferentiatedphenotype of CTNs, alterations in signaling cascades that favorproliferation, but not differentiation, are likely candidatesfor tumor induction and progression. The importance of RAS mutationsfor the development of benign nodules with follicular histologyis still in question. However, differentially expressed genesin the context of their signaling cascades could define aberrantsignaling in CTNs. Therefore, we investigated gene expressionin 22 CTNs and their normal surrounding tissue using AffymetrixGeneChips. Most prominently, data analysis revealed an increasedexpression of cell cycle-associated genes and a special relevanceof protein kinase C signaling, whereas no evidence of RAS-MAPKsignaling in CTNs was found. Moreover, we determined 31 differentiallyregulated genes in CTNs, including several histone mRNAs. Takentogether, these results explain recent findings showing an increasedproliferation in CTNs and draw attention to protein kinase Csignaling, but away from RAS-MAPK signaling, as being involvedin the etiology of CTNs.
This article has been cited by other articles:
K. Krause, B. Jessnitzer, and D. Fuhrer Proteomics in Thyroid Tumor Research
J. Clin. Endocrinol. Metab.,
August 1, 2009;
94(8):
2717 - 2724.
[Abstract][Full Text][PDF]
A. Hebrant, J. Van Sande, P. P. Roger, M. Patey, M. Klein, C. Bournaud, F. Savagner, J. Leclere, J. E. Dumont, W. C. G. van Staveren, et al. Thyroid Gene Expression in Familial Nonautoimmune Hyperthyroidism Shows Common Characteristics with Hyperfunctioning Autonomous Adenomas
J. Clin. Endocrinol. Metab.,
July 1, 2009;
94(7):
2602 - 2609.
[Abstract][Full Text][PDF]
S. Karger, C. Weidinger, K. Krause, S.-Y. Sheu, T. Aigner, O. Gimm, K.-W. Schmid, H. Dralle, and D. Fuhrer FOXO3a: a novel player in thyroid carcinogenesis?
Endocr. Relat. Cancer,
March 1, 2009;
16(1):
189 - 199.
[Abstract][Full Text][PDF]
M. Eszlinger, K. Krohn, S. Hauptmann, H. Dralle, T. J. Giordano, and R. Paschke Perspectives for Improved and More Accurate Classification of Thyroid Epithelial Tumors
J. Clin. Endocrinol. Metab.,
September 1, 2008;
93(9):
3286 - 3294.
[Abstract][Full Text][PDF]
K. Krause, S. Karger, S.-Y. Sheu, T. Aigner, R. Kursawe, O. Gimm, K.-W. Schmid, H. Dralle, and D. Fuhrer Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis
J. Endocrinol.,
August 1, 2008;
198(2):
291 - 299.
[Abstract][Full Text][PDF]
K. Krause, M. Eszlinger, O. Gimm, S. Karger, C. Engelhardt, H. Dralle, and D. Fuhrer TFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1390 - 1393.
[Abstract][Full Text][PDF]
M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors
Endocr. Rev.,
May 1, 2007;
28(3):
322 - 338.
[Abstract][Full Text][PDF]
K. Krause, S. Karger, A. Schierhorn, S. Poncin, M.-C. Many, and D. Fuhrer Proteomic Profiling of Cold Thyroid Nodules
Endocrinology,
April 1, 2007;
148(4):
1754 - 1763.
[Abstract][Full Text][PDF]
K. Krause, S. Karger, O. Gimm, S.-Y. Sheu, H. Dralle, A. Tannapfel, K. W. Schmid, C. Dupuy, and D. Fuhrer Characterisation of DEHAL1 expression in thyroid pathologies
Eur. J. Endocrinol.,
March 1, 2007;
156(3):
295 - 301.
[Abstract][Full Text][PDF]
J. Galle, D. Sittig, I. Hanisch, M. Wobus, E. Wandel, M. Loeffler, and G. Aust Individual Cell-Based Models of Tumor-Environment Interactions: Multiple Effects of CD97 on Tumor Invasion
Am. J. Pathol.,
November 1, 2006;
169(5):
1802 - 1811.
[Abstract][Full Text][PDF]
M. Eszlinger, M. Wiench, B. Jarzab, K. Krohn, M. Beck, J. Lauter, E. Gubala, K. Fujarewicz, A. Swierniak, and R. Paschke Meta- and Reanalysis of Gene Expression Profiles of Hot and Cold Thyroid Nodules and Papillary Thyroid Carcinoma for Gene Groups
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1934 - 1942.
[Abstract][Full Text][PDF]
D Fuhrer, M Eszlinger, S Karger, K Krause, C Engelhardt, D Hasenclever, H Dralle, and R Paschke Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours
Eur. J. Endocrinol.,
May 1, 2005;
152(5):
785 - 790.
[Abstract][Full Text][PDF]